← Eichor
Condition: Steroid Refractory Acute Graft Versus Host Disease Sr Agvhd Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Steroid Refractory Acute Graft Versus Host Disease Sr Agvhd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
NA · 1 location(s) · Anhui Provincial Hospital · NCT06321198Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Dise
Phase 4 · 17 location(s) · Novartis Pharmaceuticals · NCT06462469
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.